Varex Imaging (VREX) Cash & Equivalents (2016 - 2026)

Varex Imaging (VREX) has 11 years of Cash & Equivalents data on file, last reported at $85.3 million in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $85.3 million, down 58.41% year-over-year; the trailing twelve-month figure through Apr 2026 was $85.3 million (down 58.41% YoY), and the FY2025 annual result was $145.0 million, down 14.05% from the prior year.
• Cash & Equivalents slipped to $85.3 million in Q2 2026 per VREX's latest filing, from $119.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $205.1 million in Q2 2025 and troughed at $81.5 million in Q4 2022.
• A 5-year average of $131.6 million and a median of $136.4 million in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2026: Cash & Equivalents surged 73.37% in 2023, then sank 58.41% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $81.5 million in 2022, then surged by 73.37% to $141.3 million in 2023, then grew by 19.39% to $168.7 million in 2024, then dropped by 14.05% to $145.0 million in 2025, then plunged by 41.17% to $85.3 million in 2026.
• Business Quant data shows VREX's Cash & Equivalents at $85.3 million in Q2 2026, $119.5 million in Q1 2026, and $145.0 million in Q4 2025.